T-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA IN MACEDONIAN PATIENTS WITH NIJMEGEN BREAKAGE SYNDROME
Kocheva SA, Martinova K, Antevska-Trajkova Z, Coneska-Jovanova B, Eftimov A, Dimovski AJ
*Corresponding Author: Svetlana A. Kocheva, M.D., Ph.D., Department of Hematology and Oncology, University Children’s Hospital, Mother Teresa 17, 1000 Skopje, Macedonia. Tel:+38-971-378-184. E-mail: svetlana.kocheva@t.mk
page: 91

DISCUSSION

Nijmegen breakage syndrome has been reported in different populations, but so far, most of the patients have been of Slavic origin and carry a typical mutation (657 del5) on the NBS1 gene [1,2]. To the best of our knowledge, this is the first family with NBS reported from Macedonia. B-cell lymphomas are the most frequently encountered malignancies in NBS, but cases of precursor T-cell, B-cell leukemia or myeloid leukemia, have also been reported [13,14]. Data from the Nijmegen registry indicate that patients with NBS develop cancer before the age of 21 years [1]. The majority of lymphomas in NBS were diagnosed in patients younger than 15 years of age with lymphomas as the leading cause of death [1,2]. Due to the small number of patients with NBS and NHL, experience related to their treatment is limited [13,14]. The treatment outcome is poor, and drug dose reductions are warranted to reduce serious toxic effects in these patients. Our patients developed T-NHL and T-ALL at the age of 7 and 9.5 years, respectively. The first patient received more than 80.0% of the recommended doses of chemotherapy. During treatment, no major toxic or infectious complications were observed. He achieved a complete remission that lasted for 21 months. The remission was not achieved in his brother and he died after a very brief and severe episode of a gram-negative sepsis and SIRS. Immunodeficiency in NBS is significant, affecting both the humoral and cellular immunity but it is highly variable, with a tendency to progress over time [14]. In our patients, we found a normal humoral immune system (cellular immunity was not tested). The diagnosis of NBS was established based on the clinical characteristics and molecular analyses of the NBS1 gene. The constitutional karyotypes of the NBS patients were normal. Cultured T cells often show a poor proliferative capacity, making the cytogenetic analysis far from easy. Early diagnosis of NBS is very important in order to avoid severe recurrent infections by employing appropriate prophylaxis in order to avoid unnecessary exposure to radiation for diagnostic purposes and the adverse reactions of the radiotherapy for the treatment of malignant tumors. It is important in cases presenting with malignancy and suggestive clinical features, that the diagnosis is confirmed prior to the initiation of treatment. Diagnosis on a genetic level provides prevention of the disease in families who are at an increased risk for having a sick child with NBS. Establishing an early genetic diagnosis will provide prenatal diagnosis in each successive pregnancy and prevent the recurrence of the disease in the family.



Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006